VIVEVE MEDICAL, INC. VIVE Income Statement

Viveve medical, inc. (VIVE)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Revenue
4,859	6,567	9,588	13,357	17,830	18,517	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	7,141	5,441	4,176	2,693	1,447	712	201	0	-	0	0	-	152	1,209	1,417	1,408	1,080	784	599	634	671	0	0	0
Cost of revenue
4,739	5,551	6,788	9,016	10,786	11,197	10,719	9,451	8,577	7,844	7,011	6,110	5,295	4,612	3,581	2,840	1,871	985	528	126	97	50	-91	-105	6	182	548	631	707	541	379	312	299	426	0	0	0
Gross profit
120	1,016	2,800	4,341	7,044	7,320	8,427	8,944	7,369	7,444	5,628	4,308	3,603	2,529	1,860	1,336	822	462	167	2	31	40	-391	-390	-202	-30	661	786	701	539	405	287	335	245	0	0	0
Operating expenses:
Research and development
7,747	8,590	9,577	11,570	12,340	13,616	13,921	13,943	13,711	12,343	11,344	9,934	8,957	8,365	7,855	7,316	5,939	4,988	3,677	2,735	2,077	1,426	677	282	412	772	1,702	2,074	2,070	2,031	2,072	1,835	1,654	1,212	0	0	0
Selling, general and administrative
20,102	22,363	28,375	32,457	36,364	38,669	36,632	34,887	32,312	28,831	24,114	20,017	15,770	12,868	10,744	9,229	8,435	7,464	6,051	6,083	5,074	4,276	4,326	3,070	3,223	3,129	2,916	3,058	2,657	2,633	2,493	2,410	2,513	2,445	0	0	0
Restructuring costs
-	742	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
27,849	31,695	38,694	44,769	49,446	52,285	50,553	48,830	46,023	41,174	35,458	29,951	24,727	21,233	18,599	16,545	14,374	12,452	9,728	8,818	7,151	5,702	5,004	3,352	3,635	3,901	4,618	5,132	4,727	4,664	4,565	4,245	4,167	3,657	0	0	0
Loss from operations
-27,729	-30,679	-35,894	-40,428	-42,402	-44,965	-42,126	-39,886	-38,654	-33,730	-29,830	-25,643	-21,124	-18,704	-16,739	-15,209	-13,552	-11,990	-9,561	-8,816	-7,120	-5,662	-5,395	-3,742	-3,837	-3,931	0	0	0	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	0	-	-	-	-	-	-	-	-
Gain on the sale of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-
Loss from operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,160	-3,958	-3,792	-3,372	0	0	0
Interest expense, net
3,448	4,354	4,652	4,549	4,418	4,372	4,023	3,694	3,976	3,169	2,661	2,105	1,525	1,370	1,207	1,100	440	415	470	508	474	567	488	493	483	447	543	524	579	555	488	467	466	396	0	0	0
Other expense, net
-241	-161	-106	-59	12	13	-25	-37	-54	-60	-64	-61	-51	-37	-22	-9	-16	-21	-22	-14	21	49	41	0	0	-	0	-	-	-	-	-	-	-	-	-	-
Net loss from consolidated companies
-38,123	-41,899	-40,652	-45,036	-46,808	-49,324	-46,174	-43,617	-42,684	-36,959	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,990	0	0	0
Loss from minority interest in limited liability company
-684	-627	-563	-553	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from minority interest in limited liability company
-	-	-	-	-	-	-	-	0	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Foreign currency transaction gains (losses)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	24	-7	14	0	0	0	-	-	-	-
Financing costs associated with convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	530	0	0	0
Change in fair value of warrant and option liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	0	-	-	-	-	-808	0	0	0
Financing costs associated with convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Change in fair value of warrant and option liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-
Change in fair value of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	3,302	-229	-2,024	-4,272	-3,139	-2,783	-1,894	0	0	0
Loss on extinguishment of convertible notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-
Total other income (expense)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	4,320	-5,390	-4,262	-8,257	-5,695	-4,958	-3,618	0	0	0
Comprehensive and net loss
-38,807	-42,526	-41,201	-45,549	-47,341	-49,981	-46,713	-44,024	-42,933	-36,959	-32,555	-27,809	-22,700	-20,111	-17,968	-16,318	-14,008	-12,426	-13,623	-12,908	-7,573	-6,180	-4,889	-3,257	2,360	-4,317	0	0	0	-	-	-	-	-	-	-	-
Series B convertible preferred stock dividends
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Benefit for income taxes from continuing operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-492	0	0	0
Net loss from continuing operations, net of income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,498	0	0	0
Income from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	53	0	0	0
Gain on sale of discontinued operations, net of provision for income taxes of $492
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	687	0	0	0
Net income from discontinued operations, net of income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	740	0	0	0
Net loss attributable to common stockholders
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-8,387	-12,417	-9,653	-8,750	-5,758	0	0	0
Net loss per share of common stock:
From loss on continuing operations attributable to common stockholders (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.02	-0.01	-0.02	-0.16
From income on discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00
From gain on sale of discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	-0.02	0.04
Basic and diluted (in dollars per share)
-0.82	0.96	-13.51	-0.21	-21.63	-120.99	-39.07	-0.37	-0.49	-0.50	-0.50	-0.54	-0.57	-0.51	-0.46	-0.66	-0.55	-0.20	-0.50	-0.67	-1.10	37.12	-1.76	-15.20	-21.43	-	-0.23	-	-	-	-	-	-0.22	-0.04	-0.01	-0.02	-0.12
Weighted average shares used in computing net loss per common share:
Basic and diluted (in shares)
8,930	-42,555	588	46,494	463	-56,224	314	31,305	25,846	19,541	19,408	19,373	11,663	10,685	10,630	8,080	7,493	6,926	6,418	4,454	2,293	17,937	1,419	52	52	-	3,743	-	41,670	-	-	-	30,357	-	-	-	-
Net loss per weighted average share, basic (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	0.12	-0.19	-	-0.10	-0.05	-	-	-	-	-
Net loss per weighted average share, diluted (in Dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.01	-	-	-	0.01	-	-	-	-	-	-	-	-	-
Basic (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	135,093	-	-	-	63,922	-	-	30,397	30,983	-	-90,931	30,351	30,351	30,351
Diluted (in Shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	288,092	-	-	-	137,764	-	-	-	-	-	-	30,351	30,351	-